A. Takagi, H. Ikemura, T. Matsuzaki, M. Sato, K. Nomoto et al., Relationship between the in vitro response of dendritic cells to Lactobacillus and prevention of tumorigenesis in the mouse, Journal of Gastroenterology, vol.450, issue.9, pp.661-670, 2008.
DOI : 10.4049/jimmunol.168.1.171

M. He and B. Shi, Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics, Cell & Bioscience, vol.17, issue.6, p.54, 2017.
DOI : 10.1016/j.cmet.2013.05.004

J. Uronis, M. Muhlbauer, H. Herfarth, T. Rubinas, G. Jones et al., Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility, PLoS ONE, vol.4, issue.6, 2009.
DOI : 10.1371/journal.pone.0006026.g007

I. Sobhani, J. Tap, F. Roudot-thoraval, J. Roperch, S. Letulle et al., Microbial Dysbiosis in Colorectal Cancer (CRC) Patients, PLoS ONE, vol.228, issue.1, 2011.
DOI : 10.1371/journal.pone.0016393.s001
URL : https://hal.archives-ouvertes.fr/hal-01190486

J. Marchesi, B. Dutilh, N. Hall, W. Peters, R. Roelofs et al., Towards the Human Colorectal Cancer Microbiome, PLoS ONE, vol.6, issue.1, 2011.
DOI : 10.1371/journal.pone.0020447.s008
URL : https://doi.org/10.1371/journal.pone.0020447

Z. Gao, B. Guo, R. Gao, Q. Zhu, and H. Qin, Microbiota dysbiosis is associated with colorectal cancer, Front Microbiol, 2015.
DOI : 10.3389/fmicb.2015.00020
URL : https://www.frontiersin.org/articles/10.3389/fmicb.2015.00020/pdf

Y. Zhan, P. Chen, W. Sadler, F. Wang, S. Poe et al., Gut Microbiota Protects against Gastrointestinal Tumorigenesis Caused by Epithelial Injury, Cancer Research, vol.73, issue.24, pp.7199-210, 2013.
DOI : 10.1158/0008-5472.CAN-13-0827
URL : http://cancerres.aacrjournals.org/content/canres/73/24/7199.full.pdf

T. Rochat, L. Bermudez-humaran, J. Gratadoux, C. Fourage, C. Hoebler et al., Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice, Microbial Cell Factories, vol.6, issue.1, pp.22-32, 2007.
DOI : 10.1186/1475-2859-6-22

L. Watterlot, T. Rochat, H. Sokol, C. Cherbuy, I. Bouloufa et al., Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice, International Journal of Food Microbiology, vol.144, issue.1
DOI : 10.1016/j.ijfoodmicro.2010.03.037
URL : https://hal.archives-ouvertes.fr/hal-00600679

J. Leblanc, D. Carmen, S. Miyoshi, A. Azevedo, V. Sesma et al., Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn's disease in mice, Journal of Biotechnology, vol.151, issue.3, pp.287-93, 2011.
DOI : 10.1016/j.jbiotec.2010.11.008

M. Lenoir, D. Carmen, S. Cortes-perez, N. Lozano-ojalvo, D. Munoz-provencio et al., Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer, Journal of Gastroenterology, vol.12, issue.4, pp.862-73, 2016.
DOI : 10.1038/ni.2002
URL : https://hal.archives-ouvertes.fr/hal-01532576

E. Acedo-felix and G. Perez-martinez, Significant differences between Lactobacillus casei subsp. casei ATCC 393T and a commonly used plasmid-cured derivative revealed by a polyphasic study, INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, vol.53, issue.1, pp.67-75, 2003.
DOI : 10.1099/ijs.0.02325-0
URL : http://ijs.microbiologyresearch.org/deliver/fulltext/ijsem/53/1/67.pdf?itemId=/content/journal/ijsem/10.1099/ijs.0.02325-0&mimeType=pdf&isFastTrackArticle=

B. Lamas, M. Richard, V. Leducq, H. Pham, M. Michel et al., CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands, Nature Medicine, vol.3, issue.6, 2016.
DOI : 10.1373/clinchem.2004.037465
URL : https://hal.archives-ouvertes.fr/hal-01314089

P. Lanfranca, M. Lin, Y. Fang, J. Zou, W. Frankel et al., Biological and pathological activities of interleukin-22, Journal of Molecular Medicine, vol.276, issue.Suppl 1, pp.523-557, 2016.
DOI : 10.1074/jbc.M007837200